Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Water retention in the tear film is a complex process involving multiple molecular components and mechanisms that work together to maintain hydration of the ocular surface. Key factors include the lipid layer's role in preventing evaporation, the aqueous layer's secretion of fluid, mucin's ability to form a hydrated gel, and electrolyte regulation of osmolarity. Disruption of any of these components can lead to tear film instability and dry eye disease.
Various, depending on the specific drug. Examples: Artificial tears provide lubrication and hydration; Cyclosporine and lifitegrast reduce inflammation; Corticosteroids suppress inflammation; Omega-3 fatty acids may improve meibomian gland function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Water Retention in Tear Film.